FindTrial
Sign In

Application of Gene Polymorphism and Molecular Imaging in Precision Management System of Heart Failure Center

Application of Gene Polymorphism and Molecular Imaging in Precision Management System of Heart Failure Center

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019869
Enrollment
Unknown
Registered
2018-12-02
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Case series:Cardiopulmonary rehabilitation therapy

Sponsors

Qingdao Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: Heart failure patients of grade II-IV of cardiac function were diagnosed according to the diagnostic criteria of Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2018; there were no verbal communication disorders such as dementia, mental retardation, deafness and dumbness, psychiatric history; there were no physical disabilities and movement disorders; and they signed the informed consent for scientific research and application of specimens.

Exclusion criteria

Exclusion criteria: Age > 75 years old; Pregnancy; Poor compliance; Complicated with severe liver and kidney diseases; Complicated with motor dysfunction can not be rehabilitated.

Design outcomes

Primary

MeasureTime frame
HAMD-17;HAMA;the 6 minute walk te;EF;NT-pro BNP;SF-36;(MTHFR)677T;Hcy;—

Countries

China

Contacts

Public ContactGang YIN

Qingdao Central Hospital

simouse@sina.com+86 17805325655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026